z-logo
open-access-imgOpen Access
Minocycline decreases blood glucose and triglyceride levels and reverses histological and immunohisto-chemical alterations in pancreas, liver and kidney of alloxan-induced diabetic rats
Author(s) -
S. Barros Viana Glauce,
X. Pessoa Igor,
L. Tavares Ferreira Pollyana,
Germano G. Carvalho Antnio,
Adilfa O. Garcia Francisca,
M. Siqueira Menezes Silvana,
Rose Tavares Neves Kelly,
Paula Negreiros Nunes Alves Ana,
Santos Cerqueira Gilberto,
Anne C. Brito Gerly
Publication year - 2014
Publication title -
journal of diabetes and endocrinology
Language(s) - English
Resource type - Journals
ISSN - 2141-2685
DOI - 10.5897/jde2014.0077
Subject(s) - alloxan , diabetes mellitus , medicine , endocrinology , oxidative stress , kidney , triglyceride , minocycline , glibenclamide , cholesterol , chemistry , biochemistry , antibiotics
Increasing evidence suggests that oxidative stress and inflammation play major roles in diabetes mellitus and its complications. Furthermore, hyperglycemia increases the production of free radicals, resulting in oxidative stress. Minocycline presents potent anti-inflammatory and antioxidant activities, as evaluated by in vivo and in vitro models. In the present study, the minocycline anti-diabetic effect was assessed in the model of alloxan-induced diabetes. Alloxan was injected to male Wistar rats (50 mg/kg, intravenously), and their blood was collected 48 h later and also after treatments, for measurements of glycemia, triglycerides, cholesterol and liver transaminases. Groups of untreated diabetic controls and diabetic treated with minocycline (1 to 50 mg/kg, peritoneally, p.o.) or glibenclamide (5 mg/kg, p.o., as reference), for different periods, were used. Furthermore, slices of pancreas, liver and kidney were submitted to histological and immunohistochemical analyses. While significant decreases in glucose and triglycerides were shown at the 5th and mainly at the 30th days after minocycline treatments, as compared to the untreated diabetic group, no changes were observed in total cholesterol, alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels. Histological analyses of pancreas, liver and kidney showed that minocycline significantly reversed tissue alterations, as those seen in untreated diabetic animals. Besides, minocycline also reduced tumor necrosis factor (TNF)-alpha, cyclooxygenase (COX)-2 and inducible nitric oxide synthase (iNOS) expressions. The beneficial minocycline effects in diabetes could be due, at least partly, to its anti-inflammatory and antioxidant properties, indicating that this drug may be a therapeutic alternative in diabetes mellitus and other pathological conditions where inflammation plays a significant role. Key words: Minocycline, diabetes, inflammation, hyperglycemia, hypertriglyceridemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom